Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052509
Filing Date
2020-11-09
Accepted
2020-11-09 16:14:26
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbrx-10q_20200930.htm   iXBRL 10-Q 2141441
2 EX-31.1 fbrx-ex311_6.htm EX-31.1 19131
3 EX-31.2 fbrx-ex312_8.htm EX-31.2 19271
4 EX-32.1 fbrx-ex321_10.htm EX-32.1 8910
5 EX-32.2 fbrx-ex322_9.htm EX-32.2 8899
  Complete submission text file 0001564590-20-052509.txt   6109325

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20200930.xsd EX-101.SCH 37862
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbrx-20200930_cal.xml EX-101.CAL 29893
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbrx-20200930_def.xml EX-101.DEF 129137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20200930_lab.xml EX-101.LAB 329193
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20200930_pre.xml EX-101.PRE 249462
11 EXTRACTED XBRL INSTANCE DOCUMENT fbrx-10q_20200930_htm.xml XML 860370
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 201297845
SIC: 2834 Pharmaceutical Preparations